The Federal Circuit rejected Magnolia Medical Technologies Inc.’s bid to revitalize a patent claim concerning a blood samples device after an administrative tribunal affirmed an examiner’s rejection. Claim 1 of US Patent No. 10,039,483 is anticipated and therefore invalid, the US Court of Appeals for the Federal Circuit said Thursday in an unsigned opinion. Magnolia had argued its claim limitations weren’t found in a prior art reference.